Changes in the intestinal microbiota from adulthood through to old age

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

Vaccines for the elderly

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-C. Lagier Clinical Microbiology and Infection

Benchmarking inappropriate empirical antibiotic treatment

New and old risk-factors for Toxoplasma gondii infection: prospective cross-sectional study among military personnel in the Czech Republic P. Kolbekova,

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects K. Ekelund, P. Skinhøj, J. Madsen, H.B.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Non-antibiotic strategies for sepsis

Surveillance of Legionnaires’ disease in Austria

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Results from a mathematical model for human monocytic ehrlichiosis

Impact of antibiotic restrictions: the pharmaceutical perspective

Vector control: a cornerstone in the malaria elimination campaign

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

R. Karakus, K. Caglar, C. Aybay Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

CMI editorial report 2011 Clinical Microbiology and Infection

Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes S. Ladhani,

Clinical and microbiological characteristics of Nocardiosis including those caused by emerging Nocardia species in Taiwan, 1998–2008 C.-K. Tan, C.-C.

Elements of design: the knowledge on which we build

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

Recent developments in staphylococcal scalded skin syndrome

Symposia and Oral Presentations

The practice of travel medicine in Europe

Antibacterial drug discovery in the 21st century

Community-acquired pneumonia: epidemiologic and clinical consideration

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Benchmarking inappropriate empirical antibiotic treatment

Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial

Training in infectious diseases and tropical medicine in Britain

A.P. Underwood, J. Green Clinical Microbiology and Infection

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

Vaccines for the elderly

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Z. Erjavec, H. Kluin-Nelemans, P.E. Verweij

Survival of rhinoviruses on human fingers

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Changes in the intestinal microbiota from adulthood through to old age P.W. O'Toole Clinical Microbiology and Infection Volume 18, Pages 44-46 (July 2012) DOI: 10.1111/j.1469-0691.2012.03867.x Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Potential modulation targets for intestinal microbiota in older persons. Modulation could be by way of dietary supplementation or probiotic supplementation. Desirable elements in the microbiota are in green; status unclear in grey; microbiota components to be reduced are in red. Clinical Microbiology and Infection 2012 18, 44-46DOI: (10.1111/j.1469-0691.2012.03867.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions